Green tea (Cammellia sinensis) attenuates ventricular remodeling after experimental myocardial infarction

International Journal of Cardiology

Volumn 225, Issue , 2016, Pages 147-153

  Lustosa, Beatriz B ^a   Polegato, Bertha ^a   Minicucci, Marcos ^a   Rafacho, Bruna ^a   Santos, Priscila P ^a   Fernandes, Ana Angélica ^a   Okoshi, Katashi ^a   Batista, Diego ^a   Modesto, Pamela ^a   Gonçalves, Andrea ^a   Pereira, Elenize J ^a   Pires, Vanessa ^a   Paiva, Sergio ^a   Zornoff, Leonardo ^a   Azevedo, Paula S ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Antioxidant; Cardiac remodeling; Green tea; Myocardial infarction

Indexed keywords

CARBONYL DERIVATIVE; CASPASE 3; GELATINASE A; GLUCOSE; GLYCOGEN; LIPID; PLANT MEDICINAL PRODUCT; POLYPHENON 60; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PYRUVATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR NRF2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; PLANT EXTRACT; TEA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DIET SUPPLEMENTATION; ECHOCARDIOGRAPHY; ENERGY METABOLISM; ENZYME ACTIVITY; EXPERIMENTAL MYOCARDIAL INFARCTION; EXTRACELLULAR MATRIX; FATTY ACID OXIDATION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; ISOLATED HEART; LIPID BLOOD LEVEL; MALE; MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SYSTOLIC DYSFUNCTION; TEA; ANIMAL; DRUG EFFECTS; HEART LEFT VENTRICLE FUNCTION; METABOLISM; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; MALE; MYOCARDIAL INFARCTION; PLANT EXTRACTS; RATS; RATS, WISTAR; TEA; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84990847685     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.09.092     Document Type: Article

References (48)

1. [1] Pfeffer, M.A., Braunwald, E., Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81 (1990), 1161–1172.
2. [2] Azevedo, P.S., Polegato, B.F., Minicucci, M.F., Paiva, S.A., Zornoff, L.A., Cardiac remodeling: concepts, clinical impact, pathophysiological mechanisms and pharmacologic treatment. Arq. Bras. Cardiol. 106 (2016), 62–69.
3. [3] Giordano, F.J., Oxygen, oxidative stress, hypoxia, and heart failure. J. Clin. Invest. 115 (2005), 500–508.
4. [4] Doenst, T., Nguyen, T.D., Abel, E.D., Cardiac metabolism in heart failure: implications beyond ATP production. Circ. Res. 113 (2013), 709–724.
5. [5] Abel, E.D., Doenst, T., Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy. Cardiovasc. Res. 90 (2011), 234–242.
6. [6] Azevedo, P.S., Minicucci, M.F., Santos, P.P., Paiva, S.A., Zornoff, L.A., Energy metabolism in cardiac remodeling and heart failure. Cardiol. Rev. 21 (2013), 135–140.
7. [7] Santos, P.P., Oliveira, F., Ferreira, V.C., Polegato, B.F., Roscani, M.G., Fernandes, A.A., et al. The role of lipotoxicity in smoke cardiomyopathy. PLoS One, 9, 2014, e113739.
8. [8] Munzel, T., Gori, T., Keaney, J.F. Jr., Maack, C., Daiber, A., Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications. Eur. Heart J. 36 (2015), 2555–2564.
9. [9] Sawyer, D.B., Siwik, D.A., Xiao, L., Pimentel, D.R., Singh, K., Colucci, W.S., Role of oxidative stress in myocardial hypertrophy and failure. J. Mol. Cell. Cardiol. 34 (2002), 379–388.
10. [10] Hsieh, S.R., Cheng, W.C., Su, Y.M., Chiu, C.H., Liou, Y.M., Molecular targets for anti-oxidative protection of green tea polyphenols against myocardial ischemic injury. Biomedicine (Taipei), 4, 2014, 23.
11. [11] Wang, Z.M., Gao, W., Wang, H., Zhao, D., Nie, Z.L., Shi, J.Q., et al. Green tea polyphenol epigallocatechin-3-gallate inhibits TNF-alpha-induced production of monocyte chemoattractant protein-1 in human umbilical vein endothelial cells. Cell. Physiol. Biochem. 33 (2014), 1349–1358.
12. [12] Chowdhury, A., Sarkar, J., Chakraborti, T., Pramanik, P.K., Chakraborti, S., Protective role of epigallocatechin-3-gallate in health and disease: a perspective. Biomed. Pharmacother. 78 (2016), 50–59.
13. [13] Paiva, S.A., Novo, R., Matsubara, B.B., Matsubara, L.S., Azevedo, P.S., Minicucci, M.F., et al. Beta-carotene attenuates the paradoxical effect of tobacco smoke on the mortality of rats after experimental myocardial infarction. J. Nutr. 135 (2005), 2109–2113.
14. [14] Pfeffer, J.M., Finn, P.V., Zornoff, L.A., Pfeffer, M.A., Endothelin—a receptor antagonism during acute myocardial infarction in rats. Cardiovasc. Drugs Ther. 14 (2000), 579–587.
15. [15] Akhlaghi, M., Bandy, B., Dietary green tea extract increases phase 2 enzyme activities in protecting against myocardial ischemia–reperfusion. Nutr. Res. 30 (2010), 32–39.
16. [16] Martinez, P.F., Okoshi, K., Zornoff, L.A., Oliveira, S.A. Jr., Campos, D.H., Lima, A.R., et al. Echocardiographic detection of congestive heart failure in postinfarction rats. J. Appl. Physiol. 111 (2011), 543–551.
17. [17] Ardisson, L.P., Minicucci, M.F., Azevedo, P.S., Chiuso-Minicucci, F., Matsubara, B.B., Matsubara, L.S., et al. Influence of AIN-93 diet on mortality and cardiac remodeling after myocardial infarction in rats. Int. J. Cardiol. 156 (2012), 265–269.
18. [18] Rosa, C.M., Gimenes, R., Campos, D.H., Guirado, G.N., Gimenes, C., Fernandes, A.A., et al. Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus. Cardiovasc. Diabetol., 15, 2016, 126.
19. [19] Azevedo, P.S., Minicucci, M.F., Chiuso-Minicucci, F., Justulin, L.A. Jr., Matsubara, L.S., Matsubara, B.B., et al. Ventricular remodeling induced by tissue vitamin A deficiency in rats. Cell. Physiol. Biochem. 26 (2010), 395–402.
20. [20] Zornoff, L.A., Paiva, S.A., Minicucci, M.F., Spadaro, J., Experimental myocardium infarction in rats: analysis of the model. Arq. Bras. Cardiol. 93 (2009), 434–440 26–32.
21. [21] Azevedo, P.S., Duarte, D.R., Minicucci, M.F., Matsubara, B.B., Matsubara, L.S., Novo, R., et al. Role of lipoperoxidation in the remodeling intensification induced by beta-carotene after infarction. Arq. Bras. Cardiol. 93 (2009), 34–38.
22. [22] Ulu, N., Henning, R.H., Goris, M., Schoemaker, R.G., van Gilst, W.H., Effects of ivabradine and metoprolol on cardiac angiogenesis and endothelial dysfunction in rats with heart failure. J. Cardiovasc. Pharmacol. 53 (2009), 9–17.
23. [23] Zhang, Y., Huang, Y., Cantalupo, A., Azevedo, P.S., Siragusa, M., Bielawski, J., et al. Endothelial Nogo-B regulates sphingolipid biosynthesis to promote pathological cardiac hypertrophy during chronic pressure overload. JCI Insight, 1, 2016.
24. [24] Goncalves, A.F., Santos, P.P., Rafacho, B.P., Batista, D.F., Azevedo, P.S., Minicucci, M.F., et al. Vitamin D supplementation intensifies cardiac remodeling after experimental myocardial infarction. Int. J. Cardiol. 176 (2014), 1225–1226.
25. [25] Minicucci, M.F., Azevedo, P.S., Oliveira, S.A. Jr., Martinez, P.F., Chiuso-Minicucci, F., Polegato, B.F., et al. Tissue vitamin A insufficiency results in adverse ventricular remodeling after experimental myocardial infarction. Cell. Physiol. Biochem. 26 (2010), 523–530.
26. [26] Roehrig, K.L., Allred, J.B., Direct enzymatic procedure for the determination of liver glycogen. Anal. Biochem. 58 (1974), 414–421.
27. [27] Reznick, A.Z., Packer, L., Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 233 (1994), 357–363.
28. [28] Carolo dos Santos, K., Pereira Braga, C., Octavio Barbanera, P., Seiva, F.R., Fernandes Junior, A., Fernandes, A.A., Cardiac energy metabolism and oxidative stress biomarkers in diabetic rat treated with resveratrol. PLoS One, 9, 2014, e102775.
29. [29] Huang, J., Wang, Y., Xie, Z., Zhou, Y., Zhang, Y., Wan, X., The anti-obesity effects of green tea in human intervention and basic molecular studies. Eur. J. Clin. Nutr. 68 (2014), 1075–1087.
30. [30] Liu, G., Mi, X.N., Zheng, X.X., Xu, Y.L., Lu, J., Huang, X.H., Effects of tea intake on blood pressure: a meta-analysis of randomised controlled trials. Br. J. Nutr. 112 (2014), 1043–1054.
31. [31] Yarmolinsky, J., Gon, G., Edwards, P., Effect of tea on blood pressure for secondary prevention of cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials. Nutr. Rev. 73 (2015), 236–246.
32. [32] Larsson, S.C., Coffee, tea, and cocoa and risk of stroke. Stroke 45 (2014), 309–314.
33. [33] Pang, J., Zhang, Z., Zheng, T.Z., Bassig, B.A., Mao, C., Liu, X., et al. Green tea consumption and risk of cardiovascular and ischemic related diseases: a meta-analysis. Int. J. Cardiol. 202 (2016), 967–974.
34. [34] Keske, M.A., Ng, H.L., Premilovac, D., Rattigan, S., Kim, J.A., Munir, K., et al. Vascular and metabolic actions of the green tea polyphenol epigallocatechin gallate. Curr. Med. Chem. 22 (2015), 59–69.
35. [35] Alway, S.E., Bennett, B.T., Wilson, J.C., Sperringer, J., Mohamed, J.S., Edens, N.K., et al. Green tea extract attenuates muscle loss and improves muscle function during disuse, but fails to improve muscle recovery following unloading in aged rats. J. Appl. Physiol. 118 (2015), 319–330.
36. [36] Khan, G., Haque, S.E., Anwer, T., Ahsan, M.N., Safhi, M.M., Alam, M.F., Cardioprotective effect of green tea extract on doxorubicin-induced cardiotoxicity in rats. Acta Pol. Pharm. 71 (2014), 861–868.
37. [37] Hsieh, S.R., Tsai, D.C., Chen, J.Y., Tsai, S.W., Liou, Y.M., Green tea extract protects rats against myocardial infarction associated with left anterior descending coronary artery ligation. Pflugers Arch. 458 (2009), 631–642.
38. [38] Minicucci, M.F., Azevedo, P.S., Martinez, P.F., Lima, A.R., Bonomo, C., Guizoni, D.M., et al. Critical infarct size to induce ventricular remodeling, cardiac dysfunction and heart failure in rats. Int. J. Cardiol. 151 (2011), 242–243.
39. [39] Minicucci, M.F., Azevedo, P.S., Santos, D.F., Polegato, B.F., Santos, P.P., Okoshi, K., et al. Echocardiographic predictors of ventricular remodeling after acute myocardial infarction in rats. Arq. Bras. Cardiol. 97 (2011), 502–506.
40. [40] Minicucci, M.F., Azevedo, P.S., Polegato, B.F., Paiva, S.A., Zornoff, L.A., Heart failure after myocardial infarction: clinical implications and treatment. Clin. Cardiol. 34 (2011), 410–414.
41. [41] Al-Sawaf, O., Clarner, T., Fragoulis, A., Kan, Y.W., Pufe, T., Streetz, K., et al. Nrf2 in health and disease: current and future clinical implications. Clin. Sci. (Lond.) 129 (2015), 989–999.
42. [42] Lionetti, V., Stanley, W.C., Recchia, F.A., Modulating fatty acid oxidation in heart failure. Cardiovasc. Res. 90 (2011), 202–209.
43. [43] Spinale, F.G., Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ. Res. 90 (2002), 520–530.
44. [44] DeCoux, A., Lindsey, M.L., Villarreal, F., Garcia, R.A., Schulz, R., Myocardial matrix metalloproteinase-2: inside out and upside down. J. Mol. Cell. Cardiol. 77 (2014), 64–72.
45. [45] Lambert, E., Dasse, E., Haye, B., Petitfrere, E., TIMPs as multifacial proteins. Crit. Rev. Oncol. Hematol. 49 (2004), 187–198.
46. [46] Takemura, G., Fujiwara, H., Role of apoptosis in remodeling after myocardial infarction. Pharmacol. Ther. 104 (2004), 1–16.
47. [47] Movassagh, M., Foo, R.S., Simplified apoptotic cascades. Heart Fail. Rev. 13 (2008), 111–119.
48. [48] Singh, S.S., Kang, P.M., Mechanisms and inhibitors of apoptosis in cardiovascular diseases. Curr. Pharm. Des. 17 (2011), 1783–1793.